home interviews presenters presentations links

Presenter from ASRM October 18, 2004
Optimizing the ART Process Now and in the Future: From Gonadotropins to Enhanced Evaluation of Embryonic Development

Curriculum Vitae

Richard P. Marrs, MDRichard P. Marrs, MD

View the video introduction to Dr. Marrs's presentation in Windows Media or  RealMedia
 View Dr. Marrs's  presentation 
Read the written transcript of Dr. Marrs's video introduction
Read the written transcript of Dr. Marrs's presentation
access the printable version of this page
 

 

California Fertility Partners
11818 Wilshire Blvd. #300
Los Angeles, CA 90025
310-828-4008
Email address: carmenr@lainfertility.com


Education

  • 1962-1966 - Tivy High School, Kerrville, Texas
  • 1966-1968 - Schreiner Institute, Junior College, Kerrville, Texas
  • 1968-1970 - B.A. - University of Texas, Austin, Texas
  • 1970-1974 - M.D. - University of Texas Medical Branch, Galveston, Texas
  • 1974-1976 - Residency, Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas
  • 1976-1977 - Chief Resident, Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas
  • 1977-1979 - Fellowship, Reproductive Endocrinology, University of Southern California, School of Medicine, Los Angeles, California

Certification & licensure

  • American Board of Obstetricians and Gynecologists
  • Sub-Specialty Boards Reproductive Endocrinology, American Board of Obstetrics and Gynecology
  • Texas
  • California

Honors & awards

  • 1966-1968 Academic Scholarship to Schreiner Institute
  • 1978-1979 Jeanne Kempner Fellowship Award
  • 10/21/79 Squibb Prize Paper Award; Identification of PRL Secreting Pituitary Adenoma by TRH Stimulation. Pacific Coast Fertility Society
  • 1980 Scientific Exhibit Award; Clinical and Laboratory Monitoring Methods Used in Human Menopausal Gonadotropin Therapy. American College of Obstetricians and Gynecologists Meeting
  • 1980 Senior Residents Award for Excellence in Teaching
  • 1982 Memorial Foundation Award Thesis; Clinical Application of Techniques Used In Human In Vitro Fertilization Research. 49th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society.
  • 1987-1988 President—IVF Special Interest Group. SART- Chairman, Board of Directors
  • 1998- 1999 Chairman, Academy of Assisted Reproductive Technology Professionals, Inc.
  • 1999-2000 Who’s Who in America Professional Inc.
  • 2000 Life Time Achievement Award- American Infertility Association 
  • 2000 Best Doctor in America
  • 2001 America’s Top Doctors 

Committees & boards

  • 1986 - Chairman-In Vitro Fertilization Special Interest Group Ad Hoc Committee, American Fertility Society
  • 1985-1990 - Ethics Committee, American Fertility Society
  • 1988-1994 - Technical Bulletins Committee on Gynecology American College of Obstetricians and Gynecologists
  • 1988-1992 - Scientific Advisory Board-IVF Australia
  • 1989-1991 - Scientific Advisory Board-Serono Pharmaceuticals
  • 1989-Present - Physician’s Advisory Board -Resolve, Inc.
  • 1991-1994 - NCC for the Obstetric, Gynecologic and Neonatal Nursing Specialties Board
  • 1999 –Present - Member, Board of Directors Schreiner University

Editorial review boards

  • Member, Editorial Advisory Board, Fertility and Sterility
  • Journal of In Vitro Fertilization and Embryo Transfer
  • Journal of Clinical Endocrinology and Metabolism
  • American Journal of Obstetrics and Gynecology

Faculty appointments

  • 1977-1979 - Clinical Instructor
    Department of Obstetrics and Gynecology, Los Angeles County-University of Southern California School of Medicine, Los Angeles, California
  • 1979-1992 - Assistant Clinical Professor
    University of Texas Medical Branch, Galveston, Texas
  • 1979-1982 - Assistant Professor
    Section of Endocrinology and Infertility, Department of Obstetrics and Gynecology, Los Angeles County-University of Southern California School of Medicine, Los Angeles, California
  • 1982-1986 - Associate Professor
    Section of Endocrinology and Infertility, Department of Obstetrics and Gynecology, Los Angeles County-University of Southern California School of Medicine, Los Angeles, California
  • 1986-1988 - Director, Division of Reproductive Endocrinology 
    and Infertility, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California
  • 1986-1988 - Professor
    Department of Obstetrics and Gynecology, CLA School of Medicine, Los Angeles, California
  • 1988-1993 - Director, The Institute for Reproductive Research
    The Hospital of the Good Samaritan, Los Angeles, California
  • 1991-1995 - Clinical Professor
    Department of OB/GYN, Loma Linda University School of Medicine, Loma Linda, California
  • 1992-Mar. 2003 - Director
    Center for Assisted Reproductive Medicine, Santa Monica/UCLA Medical Center, Santa Monica, California
  • 1992-Present - Managing Partner
    California Fertility Partners, Los Angeles, California

Professional memberships

  • Local
    • Los Angeles OB/GYN Society
    • Pacific Coast OB/GYN Society
  • National 
    • American College of Obstetricians and Gynecologists-Fellow
    • Pacific Coast Fertility Society
    • Society for Gynecologic Investigation
    • Endocrine Society
    • Society of Assisted Reproductive Technology (SART)

Invited lectures

1982

  • February 2, 1982 Guest Speaker, Los Angeles Obstetrical & Gynecological Forum, Los Angeles, California
  • July 22, 1982 Guest Speaker, Sigma Delta Chi, Professional Journalism Society, North Hollywood, California
  • September 14, 1982 Guest Speaker, Los Angeles Obstetrical & Gynecological Forum, Los Angeles, California
  • September 26-30, 1982 Memorial Foundation Award Thesis and Guest Speaker, Pacific Coast Obstetrical and Gynecological Society, Pebble Beach, California
  • October 24-26, 1982 Guest Speaker, Serono Clinical Colloquia on Reproduction, Carmel, California
  • November 9, 1982 Guest Speaker, Gynecological Society, San Francisco, California

1983

  • February 22, 1983 Marlowe Guest Lecturer, The Society of Obstetricians and Gynecologists of Toronto, Toronto, Canada
  • July 5-6, 1983 Committee Member, IVF Committee on Minimal Standards, American Fertility Society, Dallas, Texas

1984

  • May 14-16, 1984 Chairman and Guest Speaker, III World Congress In Vitro Fertilization and Embryo Transfer, Helsinki, Finland
  • August 9, 1984 Invited Witness, Subcommittee on Investigations and Oversight United States House of Representatives Rep. Albert Gore, Jr., Chairman Washington, DC
  • September 27-29, 1984 Program Director and Guest Speaker, International Conference on Human In Vitro Fertilization, Montreal, Canada

1985

  • August, 1985 Keynote Lecturer, IV Japanese Conference on Fertility, Tokyo, Japan
  • August, 1985 Visiting Professor, Cha Women’s Hospital, Seoul, Korea
  • August, 1985 Visiting Professor, Department of OB/GYN, Yonsei University College of Medicine, Seoul, Korea
  • November 18-22, 1985 Keynote Speaker, IV World Congress In Vitro Fertilization, Melbourne, Australia

1986

  • April 4-10, 1987 Guest Speaker, V World Congress on In Vitro Fertilization, Norfolk, Virginia

1988

  • June 1, 1988 Member Subcommittee On Regulation and Business Opportunities, Regulation of the Advanced Technologies Ad Hoc Committee United States House of Representatives, Representative Ron Wyden, Chairman, Washington, DC

1989

  • March 9, 1989 Invited Witness, Subcommittee on Regulation and Business Opportunities, Regulation of the Advanced Technologies, United States House of Representatives, Representative Ron Wyden, Chairman
    Washington, DC

1990

  • March 13, 1990 Guest Speaker, Schreiner College, Kerrville, Texas
  • October 6, 1990 Guest Speaker, Jan Behrman, MD Testimonial Dinner, Royal Oak, Michigan

1991

  • February 18-23, 1991 Invited Advisor, Epworth Hospital Infertility Medical Centre PTY. LTD, Melbourne, Australia

1992

  • February 7, 1992 Keynote Speaker, Unihealth Seminar, Universal City, California

1993

  • May 20-22, 1993 Guest Speaker, Assisted Reproductive Technologies, An International Symposium, The Westin Hotel, Chicago, Illinois

1994

  • February 8-9, 1994 Guest Speaker, Legislative Workshop on Health Reform, American Fertility Society, Washington, DC
  • March 9-11, 1994 Guest Speaker, NCC Meeting, Chicago, IL
  • May 2, 1994 Guest Speaker, OB-GYN Rounds-Advanced, Reproductive Technology-UCLA Harbor ARTs Lecture
    Torrance, CA
  • May 14, 1994 Guest Speaker, Work-up of Infertile Couples, RESOLVE, Irvine, CA
  • May 20, 1994 Committee Member, Assisted Reproductive Technology, PACLAC Regional Meeting
  • July 14-17, 1994 Guest Speaker, In Vitro Fertilization and Gamete Intra Fallopian Transfer, Mexican Association of Gynecology, Endoscopy, Microsurgery, Puerto Vallarta, Mexico 
  • July 23-28, 1994 Guest Speaker, Surrogate Carrier, University of California Los Angeles Santa Barbara, CA 
  • September 6-10, 1994 Guest Speaker, Current Controversies in Reproductive Endocrinology, SERONO Laboratories, New Brunswick, Canada
  • September 24, 1994 Committee Member, SART Interim Meeting, American Fertility Society, Palm Springs, CA
  • September 28-29, 1994 Guest Speaker, Assisted Reproductive Technologies, How do we choose the right procedure? TAP Pharmaceutical Inc., New York, NY
  • November 5, 1994 Committee Member, American Fertility Society Committee Meeting American Fertility Society 
    San Antonio, TX

1996

  • June 1-5, 1996 Guest Speaker, Mexican Association of Laparoscopy, Mexico City
  • November 2-7, 1996 Committee Member, American Fertility Society

1997

  • February 11, 1997 Guest Speaker, Assisted Reproduction Technologies, SERONO/ RESOLVE, New York, NY
  • February 26-27, 1997 Guest Speaker, Society of OB-GYN, Guadalajara, Jalisco, Mexico
  • April 21-23, 1997 Guest Speaker, Human Oocytes: From Physiology to IVF, University of Bologna, Bologna, Italy
  • June 17-20, 1997 Committee Member, VII Regional Meeting-Mexican Federation of OB-GYN, Society of OB-GYN, Endoscopy, Mexico City
  • July 22-23, 1997 Guest Speaker, In vitro Fertilization and Embryo Transfer-A Comprehensive Update, CME Office, UCLA School of Medicine, Santa Barbara, CA
  • October 17-21, 1997 Committee Member, 21st Century Art: Embracing Change, American Society Reproductive Medicine, Cincinnati, OH
  • November 14, 1997 Guest Speaker, Dilemmas in Infertility, California Hospital Medical Center, Los Angeles, CA
  • December 2-5, 1997 Guest Speaker, The ART: State of the ART Symposium, SERONO Laboratories, Hawaii, HI

1998

  • July 20 –22, 1998 Guest Speaker, Annual In vitro Fertilization and Embryo Transfer- A Comprehensive Update, CME Office, UCLA School of Medicine, Santa Barbara, CA
  • August 18, 1998 Guest Speaker, IVF and Oocyte Quality, Serono Laboratories, Inc., Oklahoma City, Oklahoma
  • September 16 – 20, 1998 Committee Member, 65th Annual Meeting, Pacific Coast Obstetrics and Gynecology Society, Pacific Coast Obstetrics and Gynecology, Whistler, British Columbia 
  • October 29 – 30, 1998 Guest Speaker, VIII National Congress of OB-GYN, Serono Laboratories, OB-GYN Mexican Congress, Puerto Vallarta, Mexico 
  • November 17 – 18, 1998 Guest Speaker, Optimizing the Success of Intrauterine Insemination: Analysis of Outcomes of 8,648 Consecutive Cycles, SERONO Laboratories – UCSF Stanford Hospital and Clinic, Stanford, CA
  • November 19 – 20, 1998 Guest Speaker, Ovarian Stimulation for In vitro Fertilization Donor Oocytes, Surrogacy and Donor Embryos, SERONO- Laboratories- University of Alabama, Birmingham, Alabama

1999

  • March 19 –20, 1999 Guest Speaker, Symposium “Implantation” Gynecology and Human Reproduction, SERONO Laboratories – Mexico S.A. de C.V.-Mexico D.F.
  • April 23, 1999 Guest Speaker, The Eighteenth Annual Health Law Symposium-Building Families Through
    Reproductive Technologies: Legal, Medical and Ethical Perspectives, Whittier Law School, Costa Mesa, California
  • May 16 –18, 1999 Guest Speaker, Fertile Ground: Your Practice, Your Patient and Infertility, The American College of OB-GYN Annual Clinical Meeting, Wyeth-Ayerst Pharmaceutical, Philadelphia, PA

    May 28 – June 1, 1999 Guest Speaker
    The ART of Donor Oocytes-State of the
    Science in Ovulation Induction and ART
    Medical University of South Carolina
    Programs In Medicine
    Charleston, South Carolina 

2000

  • January 13, 2000 Guest Speaker, Latest Advances and Success with Assisted Reproductive Technologies
    St. Mary’s Health Center – St. Louis University- Dept OB-GYN, Ferring Pharmaceutical, St. Louis, MO
  • January 15, 2000 Guest Speaker, Evolution in Changes of Using hMG and Advantages and Disadvantages of FSH, St. Mary’s Health Center-St. Louis University- Dept OB-GYN, Ferring Pharmaceutical, St. Louis, MO
  • February 5, 2000 Guest Speaker, Fertility Care in the Year 2000 and Beyond, The Ritz Carlton, Serono Labs and MDR Pharmacies, Laguna Niguel, CA
  • August 3-4, 2000 Guest Speaker, The Art of Donor Oocytes 2000, Medical University of South Carolina, Southeastern Fertility Center, P.A., Mt. Pleasant, South Carolina
  • September 12, 2000 Guest Speaker, Fertility and Family Forum: The Latest Options in Treatment and Adoption
    New York Presbyterian Hospital, Uris and Weill Auditorium, American Infertility Association, New York, NY

2001

  • June 3-5, 2001 Guest Speaker, The 3rd Annual Art of Donor Oocytes and Third Party Reproduction Conference 
    Charleston Place Hotel, Ferring Pharmaceuticals, Charleston, South Carolina
  • October 22, 2001 Guest Speaker, Modern Day Gonadotropins in IVF: Technology, Mixed Protocols and New Clinical Data, 57th Annual Meeting of the American Society for Reproductive Medicine , Orlando, Florida
  • October 24, 2001 Guest Speaker, ART: Ovarian Stimulation Session, 57th Annual Meeting of the American Society for Reproductive Medicine, Orlando, Florida

2002

  • January 27, 2002 Guest Speaker, Advances in Fertility Treatment, Phase IIIb Mixed Protocol Investigator’s
    Meeting, The Marriot Harbor Beach Resort, Ferring Pharmaceuticals, Fort, Lauderdale, Florida
  • May 31 – June 2, 2002 Guest Speaker, Ovarian Stimulation of Oocyte Donors, Including the Use of GnRH Antagonists, The 4th Annual- Art of Donor Oocytes and Third Party Reproduction Conference, Double Tree Guest Suites, Ferring Pharmaceuticals, Charleston, South Carolina
  • September 25 – 28, 2002 Guest Speaker, Preimplantation Genetic Diagnosis, The Future of Advanced Reproductive Technologies. The American College of OB/GYN, 2002 District III Annual District Meeting
    Silverado Country Club and Resort, Napa Valley, CA
  • October 5, 2002 Guest Speaker, Your Guide to Getting Pregnant, Los Angeles Times Health and Fitness Festival, Los Angeles, CA
  • October 14, 2002 Guest Speaker, Selecting the Optimal Ovulation  Induction Protocol for the Patient Undergoing In-Vitro Fertilization: An Exchange of Ideas, ASRM-58th Annual Meeting, Sheraton Seattle Hotel and Towers
    Ferring Pharmaceuticals, Seattle, Washington, D.C.

Peer review journals

  1. Kletzky OA, Marrs RP, Costin G, Bernstein G, March CM, Mishell DR Jr.;Gonadotropin insufficiency in patients with thalassemia major. J Clin Endocrinol Metab 48:901-905, 1979.
  2. Marrs RP, Kletzky OA, Teal J, Davajan V, March CM, Mishell DR Jr.; Comparison of serum prolactin, plain radiography and hypocycloidal tomography of the sella turcica in patients with galactorrhea. Am J Obstet Gynecol 135:467-469, 1979.
  3. Marrs RP, Kletzky OA, Howard WF, Mishell DR Jr.; The disappearance of human chorionic gonadotropin (hCG) and resumption of ovulation following abortion. Am J Obstet Gynecol 135:731-736, 1979.
  4. Kletzky OA, Marrs RP, Nicoloff JT; Effects of cyproheptadine on insulin-induced hypoglycemia secretion of PRL, GH and cortisol. Clin Endocrinol 13:231-234, 1980.
  5. Kletzky OA, Marrs RP, Howard WF, McCormick W, Mishell DR Jr.; Prolactin (PRL) synthesis and release during pregnancy and puerperium. Am J Obstet Gynecol 136:545-550, 1980.
  6. Marrs RP, Bertolli SJ, Kletzky OA; The use of thyrotropin-releasing hormone in distinguishing prolactin-secreting pituitary adenoma. Am J Obstet Gynecol 138:620-625, 1980.
  7. Jensen MR, Kaplan BJ, Marrs RP, March CM; Maturation value as an indicator of the serum estrogen concentration during treatment with gonadotropins. Acta Cytol 25:251-254, 1981.
  8. Kletzky OA, Marrs RP, Rundall TT, Weiss MH, Beierle JW; Monolayer and suspension culture of human prolactin-secreting pituitary adenoma. Am J Obstet Gynecol 138:660-664, 1980.
  9. Marrs RP, Kletzky OA, Mishell DR Jr.; A separate mechanism of gonadotropin recovery following pregnancy termination. J Clin Endocrinol Metab 52:545-548, 1981.
  10. Marrs RP, March CM, Mishell DR Jr.; A comparison of clinical and laboratory methods in monitoring human menopausal gonadotropin therapy. Fertil Steril 34:542-547, 1980.
  11. Roy S, Brenner P, Marrs RP, Mishell DR Jr.; Termination of early gestation with a single vaginal suppository of (15S)-15-methyl- prostaglandin F2a methyl ester. Contraception 22:137-152, 1980.
  12. March CM, Kletzky OA, Davajan V, Teal J, Weiss M, Apuzzo MLH, Marrs RP, Mishell DR Jr.; Longitudinal evaluation of patients with untreated prolactin secreting pituitary adenomas. Am J Obstet Gynecol 139:835-844,1981.
  13. Marrs RP, Kletzky OA, Mishell DR Jr.; Functional capacity of the gonadotrophs during pregnancy and the puerperium. Am J Obstet Gynecol 141:658-661, 1981.
  14. Zeidler A, Gelfand R, Tamagna E, Marrs RP, Chopp R, Kletzky OA; Pituitary gonadal function in diabetic male patients with and without impotence. Andrologia 14 (1):62-68, 1982.
  15. March CM, Marrs RP, Goebelsmann U, Mishell DR Jr.; Feedback of estradiol and progesterone upon gonadotropin and prolactin release. Obstet Gynecol 58:10-16, 1981.
  16. Marrs RP, Brenner PF, Roy S, Mishell DR Jr.; Termination of early gestation with (15S)-I5-methyl prostaglandin F2a methyl ester vaginal suppositories. Contraception 24:617-630, 1981.
  17. Vargyas JM, Marrs RP, Kletzky OA, Mishell DR Jr.; Correlation of ultrasonic measurement of ovarian follicle size and serum estradiol levels in ovulatory patients using clomiphene citrate for in vitro fertilization. Am J Obstet Gynecol 144:569-573, 1982.
  18. Lahteenmaki P, Lobo R, Marrs RP, Gibbons W, Nakamura RM, diZerega GS; Characterization of porcine granulosa cells by isopycnic gradient centrifugation. Biol Reprod 27:633-640, 1982.
  19. Berger T, Marrs RP, Saito H, Kletzky OA; Factors affecting human sperm penetration of zona free hamster ova. Am J Obstet Gynecol 145:397-401, 1983.
  20. diZerega GS, Marrs RP, Roche PC, Campeau JD, Kling 0; Identification of protein(s) in pooled human follicular fluid which suppress follicular response to gonadotropins. J Clin Endocrinol Metab 56:35-41, 1983.
  21. diZerega GS, Marrs RP, Campeau SD, Nakamura RM, Kling OA; Human granulosa cell secretion of protein(s) which suppress follicular response to gonadotropins. J Clin Endocrinol Metab 56:147-155, 1983.
  22. Marrs RP, Vargyas JM, Gibbons WE, Saito H, Mishell DR Jr.; A modified technique of human in vitro fertilization and embryo transfer.  Am J Obstet Gynecol 147:318-322, 1983.
  23. Brenner PF, Marrs RP, Roy S, Mishell DR Jr.; Termination of early gestation with 9-dexoxo-16, 16-Dimethyl-9 methylene prostaglandin E2. Contraception 26:261-277, 1983.
  24. Marrs RP, Vargyas JM, March CM; Correlation of ultrasonic measurements in human menopausal gonadotropin therapy. Am J Obstet Gynecol 145 (4):417-421, 1983.
  25.  Lahteenmaki P, Marrs RP, Schecter J, Zacharias S, Kletzky OA; Hormonal and morphologic effects of bromocriptine on normal rat pituitary and Gh3 tumor cells. Am J Obstet Gynecol 153:349, 1985.
  26. Marrs RP, Vargyas JM, Saito H, Gibbons WE, Berger T, Mishell DR Jr.; Clinical application of techniques used in human in vitro fertilization research. Am J Obstet Gynecol 146:477-481, 1983.
  27. Rossman F, d’Ablaing G III, Marrs RP; Pregnancy complicated by ruptured endometrioma. Obstet Gynecol 62:519-521, 1983.
  28. Kletzky OA, Marrs RP, Davajan V; Management of patients with hyperprolactinemia and normal or abnormal tomograms. Am J Obstet Gynecol 147:528-532, 1983.
  29. diZerega GS, Campeau JD, Lobo RA, Nakamura RM, Ujita EL, Marrs RP; Activity of a human follicular fluid protein(s) during normal and stimulated ovarian cycles. J Clin Endocrinol Metab 57:838-846, 1983.
  30. Marrs RP, Lobo R, Campeau JD, Nakamura RM, Ujita EL, diZerega GS; Correlation of human follicular fluid inhibin activity with spontaneous and stimulated follicular development. J Clin Endo Metab 55:704-709, 1984.
  31. Saito H, Berger T, Mishell DR Jr., Marrs RP; The effect of serum fractions on embryo growth. Fertil Steril 41:761-765, 1984.
  32. Saito H, Berger T, Mishell DR Jr., Marrs RP; Effect of variable concentration of serum on mouse embryo development. Fertil Steril 41:460-464, 1984.
  33. diZerega GS, Campeau JD, Ujita EL, Kling O, Marrs RP, Lobo R, Nakamura R; The possible role for a follicular protein(s) in the intraovarian regulation of folliculogenesis. Sem Reprod Endocrinol
    1:309-322, 1983.
  34. Campeau JD, Marrs RP, diZerega GS; Comparison of Chromato- focusing and isoelectric focusing for recovery of specific activity from biological fluids. J Chromatography 262:334-339, 1983.
  35. Marrs RP, Saito H, Yee B, Sato F, Brown J; Effect of variation of in vitro culture techniques upon oocyte fertilization-embryo development in human in vitro fertilization procedures. Fertil Steril 41:519-523, 1984.
  36. Marrs RP, Vargyas JM, Shangold GM, Yee B; The effect of the time of initiation of clomiphene citrate on multiple follicle development for human in vitro fertilization and embryo replacement procedures. Fertil
    Steril 41:682- 685, 1984.
  37.  Weimer SL, Campeau JD, Marrs RP, diZerega GS; Alternation of human follicular fluid plasminogen activator activity by ovarian hyperstimulation. J In Vitro Fertiliz Embryo Transfer 1:263-266, 1984.
  38. Shangold GA, Kletzky OA, Marrs RP, Mishell DR Jr.; Hyperprolactinemia: Comparison of thyrotropic-releasing hormone and tomography. Obstet Gynecol 63:771, 1984.
  39. Vargyas JM, Morente C, Shangold G, Marrs RP; The effect of different methods of ovarian stimulation for human in vitro fertilization and embryo transfer. Fertil Steril 42:745-749, 1984.
  40. Sueldo C, Marrs RP, Berger T, Kletzky OA, O'Brien T; Correlation of semen transferrin concentration and sperm fertilizing capacity. Am J Obstet Gynecol 150:528-530, 1984.
  41. diZerega GS, Marrs RP, Lobo R, Ujita EL, Brown J, Campeau JD; Correlation of inhibin and follicle regulatory protein activities with follicular fluid steroid levels in anovulatory patients. Fertil Steril 41:849-855, 1984.
  42. Berger T, Marrs RP, Moyer DL; Comparison of techniques for selection of motile spermatozoa. Fertil Steril 43:268-273, 1985.
  43. Serafini P, Yee B, Vargyas JM, Marrs RP; Development of multiple ovarian follicles for in vitro fertilization in a patient with an undiagnosed ectopic pregnancy. Fertil Steril 43:656-658, 1985.
  44. Sueldo CE, Berger T, Kletzky OA, Marrs RP; Seminal prolactin concentration and sperm reproductive capacity. Fertil Steril 43:632-635, 1985.
  45. Marrs RP, Vargyas JM, Hoffman D, Yee B; Use of various ovarian stimulation methods to improve oocyte and embryo production for human in vitro fertilization. Annuals of the New York Academy of Science 442:112- 118, 1985.
  46. Battin D, Vargyas JM, Sato F, Brown J, Marrs RP; The correlation between in vitro fertilization of human oocytes and semen profile. Fertil Steril 44:835-838, 1985.
  47. Lobo RA, diZerega GS, Marrs RP; Follicular fluid steroid levels in dysmature and mature follicles from spontaneous and hyperstimulated cycles in normal and anovulatory women. J Clin Endo Metab, 60
    (1):81-87, 1985.
  48. Serafini P, Marrs RP; Computerized staged-freezing techniques improves sperm survival and preserves penetration of zona-free hamster ova. Fertil Steril 45:854-858, 1986.
  49. Marrs RP, Lobo R, Campeau JD, Nakamura RM, Brown J, Ujita EL, diZerega GS; Correlation of human follicular fluid inhibin activity with spontaneous and induced follicle maturation. J Clin Endo Metab 58:704-709, 1984.
  50. Cha YK, Barnes R, Marrs RP, Lobo RA; Correlation of the bioactivity of LH in follicular fluid with oocyte maturity in the spontaneous cycle.  Fertil Steril 45:338-341, 1986.
  51. Vargyas JM, Kletzky OA, Marrs RP; The effect of laparoscopic follicular aspiration on ovarian steroidogenesis during the early preimplantation period. Fertil Steril 45:221, 1986.
  52. Sato F, Marrs RP; The effect of PMSG on mouse embryos fertilized in vivo or in vitro. J In Vitro Fertil & Embryo Transfer 3:353-357, 1986.
  53. Serafini P, Hauser D, Moyer D, Marrs RP; Ultrastructural sperm head configuration: correlation with motility and capacity to penetrate zona-freehamster ova before and after freezing. Fertil Steril 46:691, 1986.
  54. Serafini P, Hauser D, Moyer D, Marrs RP; Cryopreservation of human spermatozoa: Correlations of ultrastructural sperm head configuration with sperm motility and ability to penetrate zona-free hamster ova. Fertil Steril 46:691, 1986.
  55. Paulson RJ, Bernstein GS, Marrs RP, Lobo RA; Idiopathic oligospermia and peripheral androgen metabolism. Fertil Steril 46:400, 1987.
  56. Serafini P, Marrs RP; Human pre-ovulatory serum (POS) enhances the efficiency of sperm cryopreservation. Fertil Steril, 1987.
  57. Ogawa T, Marrs RP; The effect of protein supplementation on single-cell mouse embryos in vitro. Fertil Steril 47:156-161, 1987.
  58. Ogawa T, Ono T, Marrs RP; The effect of serum fractions on single-cell mouse embryos in vitro. Fertil Steril 4:153-158, 1987.
  59. Vargyas JM, Marrs RP; Endogenous luteinizing hormone (LH) release using human menopausal gonadotropins (HMG) for in vitro fertilization. (IVF) J IVF-ET, 4:107-111, 1987.
  60. Yee B, Barnes R, Vargyas JM, Marrs RP; Correlation of transvaginal ultrasound measurements with follicle number and volume at laparoscopy for in vitro fertilization. Fertil Steril 5:828-832, 1987.
  61. Marrs RP, Brown J, Sato F, Ogawa T, Yee B, Paulson R, Serafini P, Vargyas JM; Successful pregnancies from cryopreserved human embryos produced by in vitro fertilization. Am J Obstet Gynecol 156:1503-1508, 1987.
  62. Serafini P, Kerin J, Marrs RP; Management of unexpected dermoid cyst during laparoscopy for oocyte pick-up (OPU). Fertil Steril 48, 1987.
  63. Ogawa T, Marrs RP; The effect of protein supplementation on single-cell mouse embryos in vitro. Fertil Steril 47:156-161, 1987.
  64. Serafini P, Stone BA, Kerin J, Batzofin J, Quinn P, Marrs RP; An alternative approach to controlled ovarian hyperstimulation (COH) in "poor responders": Pretreatment with a GnRh analog (GnRHa). Fertil Steril 49(1):90-95, 1988.
  65. Serafini P, Stone BA, Kerin J, Batzofin J, Quinn P, Marrs RP; Occurrence of a spontaneous luteinizing hormone (LH) surge in superovulated cycles- predictive value of serum progesterone (P). Fertil Steril 49 (l):86-89, 1988.
  66. Serafini P, Stone BA, Kerin J, Batzofin J, Quinn P, Marrs RP; Spontaneous LH surge in women undergoing controlled ovarian hyperstimulation (COH) -critical analysis of monitoring parameters. Fertil Steril 49:95, 1988.
  67. Stone BA, Vargyas JM, Marrs RP, Quinn PJ, Kerin J, Batzofin J, Tan T, Serafini P; Levels of steroid and protein hormones in antral fluids of women treated with FSH, hMG, clomiphene citrate/hMG, or with hMG/FSH following pituitary down-regulation with a GnRH analog. Fertil Steril 49(2):249-257, 1988.
  68. Stone BA, Vargyas JM, Marrs RP, Quinn P, Batzofin J, Tan T, Kerin J, Serafini P; Levels of steroid and protein hormones in antral fluid of women treated with different combinations of gonadotropins, clomiphene citrate and a gonadotropin releasing hormone analog. Fertil Steril 49 (2):249-257, 1988.
  69. Stone BA, Tan T, Koopersmith TB, Quinn K, Marrs RP; Luteotropic activity in serum of women following embryo transfer in a program of in vitro fertilization. JIVFET: 5 (5) :102-109,1988.
  70. Serafini P, Batzofin J, Kerin J, Marrs RP; Pregnancy--A risk to initiation of leuprolide acetate during the luteal phase before controlled ovarian hyperstimulation. Fertil Steril 50:371-372, 1988.
  71. Kerin J, Quinn P, Stone BA, Serafini P, Batzofin J, McAllister J, Reading A D'Amico, Wade M, Marrs RP; The way forward for in vitro fertilization. Jour of Repro and Fertil Supplement 36:161-172, 1988.
  72. Stone BA, Serafini P, Quinn K, Quinn P, Kerin J, Marrs RP; Serum levels of gonadotropins and estradiol during ovarian hyperstimulation in women treated with leuprolide acetate. Obstet and Gynecol 73 (6):990-995, June, 1989.
  73. Quinn P, Stone BA, Marrs RP; Suboptimal laboratory conditions can affect pregnancy outcome following embryo transfer on Day 1 or 2 after insemination in vitro. Fertil Steril, 53, 168-170, 1989.
  74. Stone BA, Quinn K, Quinn P, Vargyas JM, Marrs RP; Tailoring a commercial radioimmunoassay to the range of levels of progesterone occurring in human serum during ovarian hyperstimulation and following embryo/gamete transfer. J of in Vitro Fertil and Embryo Trans., 1989. 6(4), 257-260. Chicago, IL.
  75. Stone BA, Quinn K, Quinn P, Vargyas JM, Marrs RP; Responses of patients to different lots of human menopausal gonadotropins during ovarian hyperstimulation. Fertil Steril. 52:5, 745-752, 1989.
  76. Stone BA, Koopersmith T, Quinn K, Quinn P, Marrs RP; Levels of interleukin-2 receptor in serum of patients during the menstrual cycle and following embryo/gamete transfer. J of Repro Immuno 20: 1989.
  77. Stone BA, Quinn K, Quinn P, Vargyas JM, Marrs RP; Tailoring a commercial radioimmunoassay to the range of levels of progesterone occurring in human serum during ovarian hyperstimulation and following embryo/gamete transfer. J of In Vitro Fertil 6 (4):257-260, 1989.
  78. Stone BA, Quinn K, Tonetta SA, Quinn P, diZerega GS, Marrs RP; Levels of follicle-stimulating hormone, prolactin, estradiol and follicle-regulatory protein in antral fluids of patients treated with leuprolide acetate. Fertil Steril.
  79. Tonetta SA, Stone BA, Marrs RP, diZerega GS; Concentrations of follicle regulatory protein, steroids and gonadotropins in antral fluids from women stimulated with metrodin and hCG. J Reprod Fert 88:389-397, 1990.
  80. Richards DW, Quinn P, Stone BA, Marrs RP; Effect of human follicular fluids from pregnant and nonpregnant patients on the development of mouse zygotes in vitro. J In Vitro Fertil 7 (l):22-27, 1990.
  81. Anderson RE, Serafini PC, Paulson RJ, Sauer MV, Marrs RP; Detection and management of pathological, non-palpable, cystic adnexal masses. Human Repro 5 (3):279-281, 1990.
  82. Stone BA, Marrs RP; Growth hormone in serum of women during the menstrual cycle and during controlled ovarian hyperstimulation. Fertil Steril 56:52-58, 1991.
  83. Marrs RP; The use of potassium - titanyl - phosphate (KTP/532) laser for laparoscopic removal of ovarian endometrioma. Am J OB/GYN 164:1622-8, 1991.
  84. Stone BA, Marrs RP; Ovarian responses to menopausal gonadotropins in groups of patients with differing basal growth hormone levels. Fertil Steril 58 (1):32-36, 1992.
  85. Stone BA, Marrs RP; Levels of growth hormone and insulin-like growth factor-1 in serum of women during early pregnancy. Infertility, 15 (2), 114-131. 
  86. Rector NA, Markusen TE, Stone BA, Marrs RP; Numbers and quality of oocytes following induction of multiple folliculogenesis in women and in mice with different lots of human menopausal gonadotropins (hMG). Fertil Steril 60 (6): 1082-1087, 1993.
  87. Marrs RP, Ringler GE, Stein AL, Vargyas JM, Stone BA; The use of surrogate gestational carriers for assisted reproductive technologies. Am J Obstet Gynecol, 1993.
  88. Hirayama T, Quinn P, Marrs RP; Assessment of sister chromotid exchange in mouse embryos produced by microsurgical fertilization. Mole Repro & Develop 
  89. Karlin BY, Marrs RP, Legasse LD; Advanced stage ovarian carcinoma presenting during infertility evaluation. Am J Obstet Gynecol, 1994.
  90. Heiner J, Nazarian D, Stone BA, Marrs RP. Early prediction of in vitro fertilization (IVF) pregnancy outcome refined: The value of simultaneously drawn estradiol (E2) levels when the initial human chorionic gonadotropin (hCG) result is low. Proceedings of the American Fertility Society, 1994, Submitted.
  91. Stone BA, Vargyas JM, Ringler GE, Stein AL, Marrs RM, Determinants of the outcome of intrauterine insemination: Analysis of outcomes of 9963 consecutive cycles. Am J. Obstet Gynecol, June 1999.

Non-peer review journals & books

  1. Lahteenmaki P, Lobo R, Marrs RP, Gibbons WE, Nakamura RM, diZerega GS; Granulosa cells heterogeneity in women treated with clomiphene and human chorionic gonadotropin. Proceedings in the IV Ovarian Workshop . G. Greenwald and P. Terranova (eds). Raven Press, 1982.
  2. diZerega GS, Kling OA, Marrs RP, Montz F, Goebelsmann U, Nakamura RM; Intraovarian regulation of follicle selection: Identification of a follicular fluid protein inhibitor in porcine and human follicular fluid. Proceedings IV Ovarian Workshop . G. Greenwald and P. Terranova (eds). Raven Press, New York, 1982.
  3. Lahteenmaki P, Lobo R, Marrs RP, Gibbons W, Nakamura R, diZerega G; Characterization of isopycnic gradient centrifugation of granulosa cells from women treated with clomiphene and hCG. Proceedings IV Ovarian Workshop. G. Greenwald and P. Terranova (eds). Raven Press, New York, 1982.
  4. Marrs RP; Clinical experience of in vitro fertilization. Proceedings from Serono Colloquia on Reproduction. No. 4, Carmel, California, October, 1982.
  5. Marrs RP; Special issue on the proceedings of the In Vitro Fertilization Workshop. Infertility Vol. #6, No. 1-4, 1983. Anibal Acosta (ed). Marcel Dekker Inc., New York.
  6. Marrs RP; Media Preparation and Quality control. Special issue on the proceedings of the In Vitro Fertilization Workshop. Infertility Vol. #5, No. 1-4, 1983. Anibal Acosta (ed). Marcel Dekker Inc. New York.
  7. Marrs RP, Girtanner RL; The use of min dose heparin in pelvic surgery. Texas Medicine 73:54, 1977.
  8. Marrs RP, Mishell DR Jr.; Placental Trophic Hormones in Symposium. Clinical Obstetrics and Gynecology 1980, Ronald Chez (ed). Harper and Row, Hagerstown, Maryland, Vol. 23, No. 3.
  9. Marrs RP; The reality of the 80's--human in vitro fertilization. Cont. OB/GYN. August, 1982.
  10. Marrs RP; Human in vitro fertilization and embryo transfer. Obstetrics and Gynecology epitomes in The Western Journal of Medicine. October, 1983.
  11. Marrs RP, Schulman JD; Historical and Practical Aspects of In Vitro Fertilization. Gynecology and Obstetrics, 1984. J. Sciarra (ed). Harper and Row, Philadelphia, PA.
  12. Marrs RP, Vargyas JM, Gibbons WE, Saito H, Yee B, Sueldo C, Kletzky OA; The Effect of Initiation of Ovulatory Stimulation and Preincubation Interval on Human In Vitro Fertilization Outcome. Clinica Obstetrica E. Ginecologica IV. Ed Crosignani. Academic Press, London, 1983.
  13. Marrs RP; Human In Vitro Fertilization. Management of Common Problems in Obstetrics and Gynecology. Daniel R. Mishell and Paul R. Brenner (eds). Medical Economics Books, New Jersey. 1983.
  14. Marrs RP, Vargyas JM, Berger T; Human In Vitro Fertilization. An Answer to Male Infertility? Seminars in Urology. E. Darracott Vaughan Jr., (eds). Grune & Stratton, New York. 1984.
  15. Marrs RP, Vargyas JM; Effects of ovarian stimulation on in vitro fertilization in the human. In Bio Chemistry of the Reproductive Years. Proceedings of the 7th O. Beckman Conference in Clinical chemistry. Page 227-236. Editor Paige K. Besch. J Am Assn for Clin Chem, publishers, Winston-Salem, North Carolina. 1984
  16. Marrs RP; Oocytes: From Development to Fertilization. Infertility, Contraception and Reproductive Endocrinology, Second Edition. Davajan and Mishell, editors. Medical Economics Books, Oradell, New Jersey. 1986
  17. Marrs RP, Vargyas JM; Human In Vitro Fertilization--State of the Art. In Infertility, Contraception and Reproductive Endocrinology, Second Edition. Davajan and Mishell, editors. Medical Economics Books, Oradell, New Jersey. 1986.
  18. Marrs RP; Tubal Surgery. Infertility, Contraception and Reproductive Endocrinology, Second Edition. Davajan and Mishell, editors. Medical Economics Books, Oradell, New Jersey. 1986.
  19. Marrs RP, Vargyas JM; Pelvic Endometriosis. Infertility, Contraception and Reproductive Endocrinology, Second Edition. Davajan and Mishell, editors. Medical Economics Books, Oradell, New Jersey. 1986.
  20. Mishell DR Jr., Marrs RP; Endocrinology of Lactation and the Puerperium. Infertility, Contraception and Reproductive Endocrinology, Second Edition. Davajan and Mishell, editors. Medical Economics Books, Oradell, New Jersey. 1986.
  21. Marrs RP; Laboratory conditions for human in vitro fertilization procedures. Clinical Obstet Gynecol 29 (1)180-189, 1986.
  22. Yee B., Marrs RP; Cryopreservation of human embryos, the latest in vitro fertilization technique. Medical Aspects of Human Sexuality.
  23. Marrs RP; Evaluation of the Infertile Female. Reproductive Failure. Editor Alan H. Decherney. Churchill Livingston, Inc. New York.
  24. Paulson R, Marrs RP; Biotechnologic advances and infertility. The Female Patient. Vol. 2: No. 2, February 1986.
  25. Marrs RP; Embryo Culture and Transfer. Gynecology and Obstetrics. Vol. 5, Chap. 98. L.B. Lippincott Company, Philadelphia, Pennsylvania.
  26. Marrs RP; Use of antiestrogens for multiple follicle development in human in vitro fertilization. New York Academy of Sciences.
  27. Paulson RJ, Marrs RP; Ovulation stimulation and monitoring for in vitro fertilization. Current Problems in Obstet Gynecol & Fertility. Yearbook Publishers, Chicago, IL. 
  28. Marrs RP, Serafini P, Kerin J; Monitoring Ovulation. Advances in Fertility and Sterility. Vol. 1, pp. 25-31. Parthenon Publishing Group, UK.
  29. Batzofin JH, Marrs RP, Serafini P, Lipschultz LI; Assisted reproductive treatments for male factor infertility. Problems in Urology, 1 (3):430-442, 1987.
  30. Marrs RP, Stone BA, Serafini PC, Quinn PJ, Reading AE, Batzofin J, Kerin J; Frontiers of Reproductive Research. Chapter 8. For Biological Applications Program, Office of Technology Assessment (OTA), Congress of the United States, Washington, DC. 1987.
  31. Marrs RP; The use of ultrasound in Reproductive Medicine. Women's Wellness Newspaper. B.C. Decker, Inc., Burlington, Ontario, Canada. 1988.
  32. Marrs RP, Serafini P, Kerin J, Batzifin J, Stone BA, Brown J, Wilson L, Quinn P; Methods used to improve gamete efficiency. In Vitro Fertilization and Other Assisted Reproduction. Annals of the New York Academy of Sciences, Vol. 541, October 31, 1988, pp. 31O-3l6. 1988.
  33. Marrs RP; Cryopreservation of Ova and Embryos. Current Therapy of Infertility--2, Philadelphia, PA, 1987.
  34. Marrs RP; Gamete and embryo cryopreservation techniques and results. Problems in Reproductive Endocrinology and Infertility, Elsevier, New York, NY, 1989.
  35. Stangel JJ, Marrs RP, Wood C; Assisted Reproduction. ACOG Update, Medical Information Systems, Inc., Port Washington, New York, 1990.
  36. Stone BA, Marrs RP; Growth hormone in serum of women during the menstrual cycle and during controlled ovarian hyperstimulation. Fertility and Sterility 56, 52-58, 1991.
  37. Stone BA, Marrs RP: Levels of growth hormone, insulin-like growth factor-1 (IGF-1) and IGF-binding protein 3 in serum of women during early pregnancy. Infertility 15 (2), 114-131, 1992.
  38. Stone BA, Marrs RP; Endocrinology of the Luteal Phase. International Conference on the Assisted Reproductive Technologies, The Hospital of the Good Samaritan, Los Angeles, CA, Serono Symposia, USA, pp. 123-131, 1992.
  39. Stone BA, Marrs RP; Ovarian responses to menopausal gonadotropins In groups of patients with differing basal growth hormone levels. Fertility and Sterility 58, (1), 32-36, 1992.
  40. Rector NA, Markusen TE, Stone BA, and Marrs RP; Numbers and quality of oocytes following induction of multiple folliculogenesis in women and in mice with different lots of human menopausal gonadotropins (hMG). Fertility and Sterility 60 (6), 1082-1087, 1993.
  41. Marrs RP; Surrogate IVF. Infertility and Reproductive Medicine of North America, W.B. Saunders CO, 1993. 
  42. Marrs RP; Gamete Intrafallopian Transfer. Infertility and Reproductive Medicine of North America, W.B. Saunders Co., 1993. Stone BA, Vargyas JM, Ringler GE, Stein AL, and Marrs RP; Determinants of the outcome of intrauterine insemination (IUI); Analysis of outcomes of 9,963 consecutive cycles. American Journal of OB-GYN. 180 (6), 1524-1534, 1999.

Abstracts

  1. Marrs RP, Kletzky OA, Teal J; Comparison between AP-lateral cone views and polytomography of the sella turcica in patients with galactorrhea. Abstracts of the American Fertility Society Meeting, March 1978, New Orleans, LA.
  2. Marrs RP, Kletzky OA, Teal J; Serum prolactin, AP-lateral cone views and hypocycloidal tomography in patients with galactorrhea. No. 911. Abstracts of the Endocrine Society Meeting, June 1978, Miami, FL.
  3. Marrs RP, Kletzky OA, Mishell DR Jr.; A separate mechanism of gonadotropin recovery follow pregnancy termination. No. 55, Abstracts of the Society for Gynecologic Investigation, March 1979, San Diego, CA.
  4. Marrs RP, Kletzky OA, Bertolli SJ; Identification of PRL secreting pituitary adenoma by TRH stimulation. No. 127, Abstracts of the Society for Gynecologic Investigation, March 1979, San Diego, CA.
  5. Kletzky OA, Marrs RP, Howard WF, McCormick W, Mishell DR Jr.; Prolactin (PRL) synthesis and release during pregnancy and puerperium. No. 171, Abstracts for the Society for Gynecologic Investigation, March 1979, San Diego, CA.
  6. Marrs RP, March CM, Mishell DR Jr.; Comparison of clinical and laboratory methods in monitoring human menopausal gonadotropin therapy. Abstracts of the American Fertility Society Meeting, February 1979, San Francisco, CA. Fertil Steril 30:745, 1978. 
  7. March CM, Marrs RP, Goebelsmann U, Nakamura RM, Mishell DR Jr.; Effects of estradiol (E2) and progesterone (P) upon PRL release. Abstracts of the Society for Gynecologic Investigation, March 1979, San Diego, CA.
  8. Kletzky OA, Marrs RP, Runadall T, Schechter J, Weiss MH, Beierle J; Monolayer culture of human prolactin secreting pituitary adenomas. Abstract of the Endocrine society, June 1979, Anaheim, CA.
  9. March CM, Marrs RP, Nakamura RM, Mishell DR Jr.; Effects of estradiol (E2) and progesterone (P) upon release. Abstracts of the Endocrine Society, June 1979, Anaheim, CA.
  10. Marrs RP, Kletzky OA, Mishell DR Jr.; A separate mechanism of gonadotropin recovery following pregnancy termination. Abstracts of the Cross Town Endocrine Club, May 17, 1979. UCLA, Los Angeles, CA.
  11. Marrs RP, Kletzky OA, Bertolli SJ; Identification of PRL secreting pituitary adenoma by TRH stimulation. Abstracts of the Pacific Coast Fertility Society. October 1979, Palm Springs, CA.
  12. Zeidler A, Tamagna E, Gelfand R, Marrs RP, Kletzky OA; Pituitary function in insulin dependent diabetes, patients with and without impotence. Abstracts of Pacific Coast Society. October 1979, Palm Springs, CA.
  13. Marrs RP, Schechter JE, Kletzky OA; Effect of bromocriptine on cultured human pituitary adenoma. Abstract of Society of Gynecologic Investigation. March 1981, St. Louis, MO.
  14. Marrs RP, Kletzky OA, Mishell DR Jr.; Functional capacity of gonadotrophs during pregnancy and the puerperium. Abstract of the society of oynecologic Investigation, March 1980, Denver, CO.
  15. Marrs RP, diZerega GS, Hodgen G, Kletzky OA; Immunological and biological activity of prolactin secreted by human pituitary adenoma. Abstract of the Society of Gynecologic Investigation. March 1980, Denver, CO.
  16. Lahteenmaki P, Lobe R, Marrs RP, Gibbons WE, Nakamura RM, diZerega GS; Folliculcgenesis in response to clomiphene therapy. Allcchronic follicular maturation. Abstract of the Pacific Coast Fertility Society. October 1981, Palm Springs, CA.
  17. Marrs RP, Higashi M, Morrow CP, O'Brien TH; The appearance of an estrogen binding protein in serum of normally cycling women. Abstract of Society for Gynecologic Investigation. March 1982, Dallas, TX.
  18. Berger TJ, Marrs RP, Saito H, Kletzky OA; Factors affecting penetration of hamster ova by human sperm. Abstract of Society for Gynecologic Investigation. March 1982, Dallas, TX.
  19. Marrs RP, March CM, Vargyas JM; Monitoring hMG ovulation with real time ultrasound. Abstract of the American Fertility Society. March 1982, Las Vegas, NV.
  20. Lahteenmaki P, Lobo R, Marrs RP, Gibbons W, Nakamura R, diZerega GS; Characterization of porcine granulosa cells by isopyonic gradient centrifugation. Ovarian Workshop, 1982.
  21. Lahteenmaki P, Lobo R, Marrs RP, Gibbons W, diZerega GS; Characterization of porcine granulosa cells by isopycnic gradient centrifugation. Endocrine Society. 1982, San Francisco, CA.
  22. diZerega GS, Marrs RP, Lobo R, Campeau J; Activity of two ovarian hormone-like proteins during spontaneous and stimulated folliculogenesis in women. Acta Endocrinologica Congress. 1983.
  23. Saito H, Marrs RP, Berger T, Brown J, Nakamura R, Mishell DR Jr.; The effect of steroid supplementation of mouse embryos grown in vitro. Presented at 10th World Congress, October 1982. San Francisco, CA.
  24. Saito H, Marrs RP, Berger T, Brown J, Nakamura R; The effect of protein supplementation on mouse embryos grown in vitro. Presented at 10th World Congress, October 1982. San Francisco, CA.
  25. Berger T, Marrs RP, Saito H, Kletzky OA; Protein source and maintenance of human sperm motility with reference to the hamster penetration test. Presented at Society for Gynecologic Investigation, March 1983. Washington DC.
  26. Sueldo C, O'Brien T, Berger T, Kletzky OA, Marrs RP; Correlation of semen transferrin concentration and sperm fertilizing capacity. Presented at the Society for Gynecologic Investigation, March, 1983. Washington, DC.
  27. Marrs RP, Lobo R, Campeau JD, Brown J, diZerega GS; Correlation of human follicular fluid inhibin activity with spontaneous and induced follicular development. Presented at the Society for Gynecologic Investigation, March 1983. Washington, DC.
  28. Marrs RP, et al; Human In vitro fertilization and embryo transfer using clomiphene citrate and chorionic gonadotropin. Presented at the American Fertility Society Meeting, 1983. San Francisco, CA.
  29. Marrs RP, et al; In vitro culturing technique of human oocytes for in vitro fertilization and embryo transfer. Presented at the American Fertility Society Meeting, 1983. San Francisco, CA.
  30. Vargyas JM, Saito H, Gibbons WE, Sueldo C, Yee B, Marrs RP; Effect of different methods of ovarian stimulation for the human in vitro fertilization embryo transfer procedure. Presented at the American Fertility Society Meeting, 1983. San Francisco, CA.
  31. Berger T, Saito H, Brown J, Marrs RP; Effects of media and incubation on the hamster penetration test. Presented at the American Fertility Society Meeting, 1983. San Francisco, CA.
  32. Marrs RP, Vargyas JM, Kletzky OA, March CM, Marrs RP, et al; Comparison of the intrafollicular hormonal mileau with fertilization of human oocytes in vitro. Presented at the Endocrine Society Meeting, June 1983. San Antonio, TX.
  33. Davajan V, Vargyas JM, Kletzky OA, March CM, Marrs RP, et al; Intrauterine insemination with washed sperm to treat infertility. Presented at the Pacific Coast Fertility Society Meeting, October 1983. Palm Springs, CA.
  34. Sueldo C, March CM, Marrs RP, Mishell DR Jr.; Improved pregnancy rate with monitoring of gonadotropin therapy by three modalities. Presented at the Pacific Coast Fertility Society Meeting, October 1983. Palm Springs, CA.
  35. Sueldo C, Berger T, Kletzky OA, Marrs RP; Seminal prolactin concentration and sperm fertilizing capacity. Presented at the Pacific Coast Fertility Society Meeting, October 1983. Palm Springs, CA.
  36. Berger T, Moyer DL, Marrs RP; Comparison of techniques for enhancement of motile sperm collection. Presented at the Endocrine Society Meeting, October 1983. Palm Springs, CA.
  37. Yee B, Ogawa T, Marrs RP; The use of pulsatile GnRH to induce time follicle rupture in mice. Presented at the Society for Gynecologic Investigation Meeting, March 1984. San Francisco, CA.
  38. Sato F, Marrs RP; Effect of ovarian hyperstimulation on chromosome aberration and sister chromatid exchange on in vitro fertilized oocytes. Presented at the American Fertility Society Meeting, 1984. New Orleans, LA.
  39. Sato F, Brown J, Marrs RP; Effect of freezing on embryo viability and sister chromatid exchange (SCE). Presented at the American Fertility Society Meeting, April 1984. New Orleans, LA.
  40. Yee B, Vargyas JM, Brown J, Marrs RP; Correlation of embryo cleavage rate and pregnancy outcome in human in vitro fertilization. Presented at the Pacific Coast Fertility Society Meeting, October 1984. Rancho Mirage, CA.
  41. Serafini P, Yee B, Marrs RP; Improved survival and in vitro penetrating ability of human sperm utilizing staged freezing techniques. Presented at the Society for Gynecologic Investigation Meeting, 1985. Phoenix, AZ.
  42. Ogawa T, Yee B, Marrs RP; The effect of protein supplementation on single cell mouse embryos in vitro. Presented at the Society for Gynecologic Investigation Meeting, 1985. Phoenix, AZ.
  43. Yee B, Ogawa T, Marrs RP; The effect of human follicular fluid from mature, immature and unstimulated follicles on mouse embryos cultured in vitro. Presented at the Society for Gynecologic Investigation Meeting, 1985. Phoenix, AZ.
  44. Serafini P, Yee B, Vargyas JM, Battin D, Marrs RP; Is it possible to predict in vitro fertility potential in subfertile males?. Presented at the Pacific Coast Fertility Society Meeting, 1985. Las Vegas, NV.
  45. Yee B, Vargyas JM, Serafini P, Marrs RP; Transvaginal approach in patients with suboptimal transabdominal ovarian ultrasound. Presented at the Pacific Coast Fertility Society Meeting, 1985. Las Vegas, NV.
  46. Ogawa T, Ono T, Marrs RP; The effect of serum fractions on single cell mouse embryos in vitro. Presented at the American Fertility Society Meeting, September 1985. Chicago, IL.
  47. Yee B, Barnes R, Vargyas JM, Marrs RP; Correlation of transvaginal ultrasound measurements with follicle numbers and volume at laparoscopy for in vitro fertilization. Presented at the American Fertility Society Meeting, September 1985. Chicago, IL.
  48. Yee B, Brown J, Marrs RP; Direct assessment of human oocyte maturity with hyaluronidase dispersion. Presented at the American Fertility Society Meeting, 1985. Chicago, IL.
  49. Serafini P, Brown J, Moyer D, Marrs RP; Fresh and frozen human semen: Correlations between sperm-head ultrastructure, motility and penetration capacity. Presented at the American Fertility Society Meeting, 1985. Chicago, IL.
  50. Cha K, Barnes R, Marrs RP, Lobo R; Oocyte maturity in the spontaneous cycle correlates with follicular fluid (FF) progesterone (PROG) levels and LH of greater biological activity. Presented at the American Fertility Society Meeting, 1985. Chicago, IL.
  51. Serafini P, Marrs RP; Pre-ovulatory serum enhances efficiency of human cryo-storage. Presented at the American Fertility Society Meeting, 1985. Chicago, IL.
  52. Spirtos T, Winer S, Richmond J, Marrs RP; Salpingitis isthmica nodosa and infertility: A retrospective analysis 1971-1985. Presented at the American Fertility Society Meeting, 1985. Chicago, IL.
  53. Paulson RJ, Paulson Y, Silva K, Cha Y, Lobo R, Yee B, Marrs RP; Hormonal dynamics of HCG-triggered ovulation: Bio-HCG and steroid Response. Presented at the Society for Gynecologic Investigation Meeting, 1986. Toronto, Canada.
  54. Cha K, Campeau J, Marrs RP, Nakamura R, Lobo R; Follicular fluid LH bioactivity and oocyte maturity in spontaneous and stimulated cycles. Presented at the Society of Gynecologic Investigation Meeting, 1986. Toronto, Canada.
  55. Marrs RP, Stone BA, Serafini P, Quinn P, Brown J, Tan T, Kerin J; Interrelationships between hormone levels in follicular fluids (FF) and the outcome of IVF in women stimulated with FSH. Presented at the Society for Gynecologic Investigation Meeting, 1987. Atlanta, GA.
  56. Marrs RP, Stone BA, Serafini P, Quinn P, Brown J, Tan T, Kerin J; Interrelationships between hormone levels in follicular fluids (FF) and the outcome of IVF in women stimulated with FSH. Presented at the Pacific Coast Fertility, 1987. Palm Springs CA.
  57. Marrs RP, Kerin J, Quinn P, Stone BA, Bernstein S, Serafini P; Effect of ovarian stimulation on the outcome of gamete transfer procedures. Presented at the American Fertility Society Meeting, 1987. Reno, NV.
  58. Marrs RP, Kerin J, Quinn P, Stone BA, Brown J, Wilson L, Serafini P; Intrauterine insemination--Is it of benefit?. Presented at the American Fertility Society Meeting, 1987. Reno, NV.
  59. Marrs RP, Kerin J, Quinn P, Stone BA, Brown J, Wilson L, Serafini P; The use of intrauterine insemination for male factor infertility. Abstract for the American Fertility Society Meeting, 1987. Reno, NV.
  60. Stone BA, Serafini P, Tan T, Quinn K, Caballero M, Quinn P, Batzofin J, Kerin J, Marrs RP; Serum levels of FSR and LH during ovarian hyperstimulation (OH) in women treated with a gonadotropin-releasing hormone analog. Presented at the Pacific Coast Fertility Society Meeting, 1988. Palm Springs, CA.
  61. Quinn P, Stone BA, Kerin J, Batzofin J, Serafini P, Marrs RP; Pregnancy outcome in human in vitro fertilization and embryo transfer (IVF-ET) following replacement of embryos at the pronucleate stage may reflect laboratory conditions. Presented at the Pacific Coast Fertility Society Meeting, 1988. Palm Springs, CA.
  62. Stone BA, Quinn P, Marrs RP, Kerin J, Serafini P; Increasing numbers of corpora lutea (CL) in early pregnant pigs by hCG treatment. Proceedings of the Society for Gynecologic Investigation, 34, 271P, 1987.
  63. Stone BA, Quinn P, Kerin J, Marrs RP, Serafini P; Effect of hCG on peripheral progestogen levels of early pregnant pigs. Proceedings of the Society for Gynecologic Investigation, 34, 272P, 1987.
  64. Serafini P, Kerin J, Bernstein S, Quinn P, Stone BA, Aloia A, Marrs RP; Spontaneous LH surge in women undergoing ovulation induction for IVF: Critical analysis of monitoring parameters. Proceedings of the Society for Gynecologic Investigation, 34, 188P, 1987.
  65. Quinn P, Stone BA, Kerin J, Serafini P, Marrs RP; A critical quality control test for IVF media and procedures. Proceedings of the American Fertility Society, AP-566, 1987.
  66. Serafini P, Moyer D, Quinn P, Kerin J, Plowman M, Hauser B, Stone BA, Marrs RP; A comparative study of five techniques for selection of motile spermatozoa with regard to their capability to enhance sperm numbers with normal sperm head ultraconfiguration (NSHU). Proceedings of the American Fertility Society, AP-577, 1987.
  67. Serafini P, Kerin J, Norbryhn G, Stone BA, Quinn P, Marrs RP; Midcycle estrogen profile and pregnancy rate in women receiving clomiphene citrate and hMG for IVF. Proceedings of the American Fertility Society, AP-667, 1987.
  68. Serafini P, Stone BA, Tan T, Norbryhn G, Kerin J, Quinn P, Marrs RP; Serum gonadotropin levels in women treated with a GnRH analog: Patients previously unresponsive to controlled ovarian hyperstimulation (COH). Proceedings of the Pacific Coast Fertility Society, 35, 60, 1987.
  69. Marrs RP, Stone BA, Serafini P, Brown J, Tan T, Kerin J; Inter-relationships between hormone levels in follicular fluids and the outcome of IVF in women stimulated with FSH. Proceedings of the Pacific Coast Fertility Society, 35, 61, 1987.
  70. Serafini P, Stone BA, Quinn P, Brown J, Wilson L, Kerin J, Marrs RP; An alternate approach to controlled ovarian hyperstimulation in 'poor responders': Pretreatment with a GnRH analog. Proceedings of the 43rd Annual Meeting of the American Fertility Society, Reno Abstract #223, p. 92, 1987.
  71. Stone BA, Tan T, Quinn P, Serafini PC, Kerin J, Batzofin J, Marrs RP; Tracking early pregnancy with a sensitive serum bioassay to chorionic gonadotropin. Proceedings of the Society for Gynecologic Investigation, 35, 397, 1988.
  72. Stone BA, Tonetta SA, Marrs RP, diZerega GS; Characterization of follicle regulatory protein in antral fluids of patients undergoing in vitro fertilization (IVF). Proceedings of the Society for Gynecologic Investigation, 35, 229,1988.
  73. Stone BA, Serafini P, Kerin J, Quinn P, Batzofin J, Caballero M, Marrs RP;Serum hormone levels as predictors of hormone and protein levels in human antral fluid. Proceedings of the Pacific Coast Fertility Society.
  74. Serafini P, Stone BA, Tan T, Batzifin J, Kerin J, Quinn P, Marrs RP; Dissynchrony between biological (B) and immunological (I) LH responses to subcutaneous administration of leuprolide acetate in poor responders. Proceedings of the Society for Gynecologic Investigation, 35, 115, 1988.
  75. Serafini P, Stone BA, Batzofin J, Kerin J, Quinn P, Marrs RP; Absence of an effect of a GnRH analog on pulsatile secretion of estradiol and testosterone in women. Proceedings of the Society for Gynecologic Investigation, 35, 217, 1988.
  76. Stone BA, Serafini P, Tan T, Quinn K, Marrs RP; Analysis of responses of in vitro fertilization patients to different batches of human menopausal gonadotropins during controlled ovarian hyperstimulation. Proceedings of the American Fertility Society, 1988.
  77. Serafini P, Stone BA, Marrs RP, Batzofin J, Quinn P, D'Amico, Kerin J; Concurrent use of pure FSH and leuprolide acetate for controlled ovarian hyperstimulation. Proceedings of the American Fertility Society, 1988.
  78. Serafini P, Stone BA, Batzofin J, D'Amico J, Kerin J, Quinn P, Marrs RP; Monitoring of follicle development after selective gonadotropin hypophysectomy. Proceedings of the American Fertility Society, 1988.
  79. Marrs RP, Serafini P, Batzonfin J, Kerin J, Brown J, Stone BA, Quinn P; A comparison of leuprolide acetate vs. conventional stimulation for controlled ovarian hyperstimulation. Proceedings of the American Fertility Society, 1988.
  80. Quinn P, Brown J, Batzofin J, Serafini P, Kerin J, Marrs RP; Pregnancies from cryopreserved human embryos utilizing various methods of cryopreservation. Proceeds of the American Fertility Society, 1988.
  81. Hood A, Brown J, Serafini P, Batzofin J, Haddy S, Marrs RP; The effect of anesthesia on GIFT outcome. Proceedings of the American Fertility Society (submitted), 1988.
  82. Batzofin J, Serafini P, Kerin J, Marrs RP; Laser laparoscopy as an adjunct to egg recovery for assisted reproductive treatment. Proceedings of the American Fertility Society (submitted), 1988.
  83. Stone BA, Quinn K, Vargyas JM, Marrs RP; In vitro bioactivity of lots of human menopausal gonadotropins (hMG) yielding different stimulation outcomes in a program of assisted conception. Proceedings of the American Fertility Society (submitted), 1989.
  84. Stone BA, Quinn K, Quinn P, Vargyas JM, Marrs RP; Responses of patients to different lots of human menopausal gonadotropins during controlled ovarian hyperstimulation. Presented at the 44th Annual Meeting of the American Fertility Society, Atlanta, GA, 1989.
  85. Stone BA, Marrs RP; Between-lot variability in chemical and biochemical properties of human menopausal gonadotropins (hMG). Proceedings of the Society for Gynecologic Investigation, 37th Annual Meeting, St. Louis, MO, 1990.
  86. Stone BA, Quinn P., Stein AL, Quinn P, Marrs RP; Growth hormone (hGH) in serum of women during the menstrual cycle and during cycles of controlled ovarian hyperstimulation (CON). Proceedings of the American Fertility Society, 1990.
  87. Stone BA, Aloia A, Vargyas JM, Quinn P, Marrs RP; Change in serum progesterone (P4) content between hCG injection and oocyte retrieval (OPU); Relationship to pregnancy outcome. Proceedings of the American Fertility Society, 1990.
  88. Stone BA, Hubbard GM, Marrs RP; Levels of growth hormone (hMG), somatgomedin C (SMC), progesterone (P4) and estradiol (E2) in serum of early pregnant women. Proceedings of the 18th Annual Meeting of the Society for Cynecologic Investigation, San Antonio, TX, 1991.
  89. Marrs RP, Quinn K, Vargyas JM, Quinn P, Stein AS, Stone BA; Follicular versus luteal phase initiation of gonadotropin releasing hormone agonist (CnRHa) - A prospective randomized trial. Pacific Coast Fertility Society, 1991.
  90. Stone BA, Marrs RP; Ovarian responses to menopausal gonadotropins (hMG) levels. Proceedings of the American Fertility Society, Orlando, FL, 1991.
  91. Stone BA, Quinn P, Hubbard GM, Vargyas JM, Stein AL, Ringler GE, Marrs RP; Progesterone (P4):estradiol (E2) mass ratios in serum (PEMR) 12h before induction of final oocyte maturation; Relationship to fertilization in vitro. Proceedings of the American Fertility Society, Orlando, FL, 1991.
  92. Hubbard GM, Stone BA, Marrs RP; The relationship between human granulosa-lutein cell (GLC) function in vitro and early luteal function in vivo following cycles of IVF/GIFT. Proceedings of the American Fertility Society, Orlando, FL, 1991.
  93. Marrs RP, Vargyas JM, Stein AL, Ringler GE, Greene J, Stone BA; Use of gonadotropin-releasing hormone (GnRH) agonist and its effects on outcome of assisted reproductive technologies (ARTS). Proceedings of the American Fertility Society, Orlando, FL., 1991.
  94. Quinn P, Stone BA, Vargyas JM, Stein AL, Marrs RP; Outcome of gamete intrafallopian transfer (GIFT) and in vitro fertilization (IVF) of supernumerary oocytes: Does the tubal environment enhance fertilization? Proceedings of the 7th World Congress on IVF and Assisted Procreations, Paris, France, 1991.
  95. Marrs RP, Ringler GE, Stein Al, Vargyas JM, Stone BA, Quinn P; The use of surrogate gestational carriers for assisted reproductive technologies. Proceedings of the 7th World Congress on IVF and Assisted Procreations, Paris, France, 1991.
  96. Hubbard GM, Stone BA, Marrs RP; Dynamics of serum estradiol (E2) following estrace (E) administration during the early follicular phase (EPP) and early luteal phase (ELP) of the menstrual cycle. Proceedings of the American Fertility Society, New Orleans, LA, 1992.
  97. Rector N, Markusen T, Stone BA, Marrs RP; A murine model for projection of responses of women to human menopausal gonadotropins during controlled ovarian hyperstimulation (COH). Proceedings of the American Fertility Society, New Orleans, LA, 1992.
  98. Stone BA, Marrs RP; Thyroid function, ovarian response to human menopausal gonadotropins (hMG) and fertilization outcome. Proceedings of the American Fertility Society, New Orleans, LA, 1992.
  99. Stone BA, Greene J, Marrs RP; Adrenal steroidogenesis, aging and
    ovarian response to human menopausal gonadotropins (hMG). Proceedings of the American Fertility Society, New Orleans, LA, 1992.
  100. Stone BA, Ringler GE, Marrs RP; Serum endocrine profiles after
    pituitary suppression with leuprolide acetate (LA): Relationship to ovarian response to human menopausal gonadotropins (hMG). Proceedings of the Society for Gynecologic Investigation, Toronto, Canada. 40, p-341, 1993.
  101. Stone BA, Marrs RP; Changes in serum hormone content with aging: Correlation with responses to controlled ovarian hyperstimulation (COH) with human menopausal gonadotropins (hMG). Proceedings of the Society for Gynecologic Investigation. Toronto, Canada. 40, p-341, 1993.
  102. Stone BA, Vargyas JM, Ringler GE, Stein AL, Marrs, RP: Incremental daily rises in serum estradiol during controlled ovarian hyperstimulation (COH). Proceedings of the American Fertility Society. Montral, Canada. 49, p-033. October 9-14, 1993.
  103. Vargyas JM, Ringler GE, Stein AL, Snoddy M, Stone BA, Marrs RP: Outcomes following transfer of frozen-thawed human embryos; Relationship to developmental stage at transfer, numbers transferred, day of transfer and cycle type. Proceedings of the American Fertility Society. Montreal, Canada. 49,October 9-14, 1993. 
  104. Stein Al, Marrs RP, Vargyas JM, Ringler GE, Snoddy M, Stone BA, Moinipanah R; MiniPercoll (miniPer) sperm preparation improves pregnancy rates for donor intrauterine inseminations (DI). Proceedings of the American Fertility Society. Montreal, Canada. 49, p-075, 1993.
  105. Heiner J, Nazarian D, Stone BA, Marrs RP; Early prediction of in vitro fertilization (IVF) pregnancy outcome refined: The value of simultaneously drawn estradiol (E2) levels when the initial human chorionic gonadotropin (hCG) result is low. Proceedings of the American Fertility Society. San Antonio, Texas. Submitted. November 5-10, 1994. 
  106. Stone BA, Faridi R, Vargyas JM, Marrs RP; Relationships between the fructose content of human semen and numbers and motility of ejaculated sperm. Proceedings of the 50th Annual Meeting of the American Fertility Society. 50, p-218. San Antonio, Texas. November 5-10, 1994.
  107. Stone BA, Faridi R., Vargyas JM, Stein AL, Ringler GE, Marrs RP; Determinants of the efficiency of motile sperm recovery through Percoll. Proceedings of the 50th Annual Meeting of the American Fertility Society. 50, p-019. San Antonio, Texas. November 5-10, 1994. 
  108. Stone BA, Vargyas JM, Stein AL, Ringler GE, Hubbard GM, Marrs RP; Serum levels of sex-hormone binding globulin (SHBG), estradiol (E2), and testosterone (T) during the luteal phase following stimulation with clomiphene citrate (CC). Proceedings of the 50th Annual Meeting of the American Fertility Society. 50, p-052. San Antonio, Texas. November 5-10, 1994. 
  109. Stein AL, Stone BA, Vargyas JM, Ringler GE, Marrs RP;  Parameters for optimizing pregnancy rates with intrauterine inseminations (IUI). Proceedings of the Pacific Coast Fertility Society. 1995. 
  110. Stone BA, Faridi R, Ong E, Vargyas JM, Marrs RP; Quantitative relationships between accessory gland secretions and semen quality. Proceedings of the American Society for Reproductive Medicine. Seattle, Washington. October 7-12, 1995.
  111. Stone BA, Faridi R, Ong E, Vargyas JM, Marrs RP; Between-month variations in semen parameters of patients presenting to a fertility clinic.  Proceedings of the American Society for Reproductive Medicine. Seattle, Washington. October 7-12, 1995.
  112. Rispler MJ, Grivas TA, Meldrum DR, Stone BA, Marrs RP, Heiner JS; A single quantitative human chorionic gonadotropin (hCG) is useful in predicting outcome of pregnancies resulting from intrauterine insemination (IUI). Proceedings of the American Society for Reproductive Medicine. Seattle, Washington. October 7-12, 1995.
  113. Qian C, Stone BA, Shiina, Y, Marrs RP; Ovarian follicular fluid steroid hormone profiles by reverse-phase HPLC. Proceedings of the Pittsburgh Conference. McCormick Place, Chicago, Illinois. Abstract #1040. March 3-8, 1996.
  114. Shiina Y, Stone BA, Qian C, Hubbard GM, Marrs RP; Changes in the hormone composition of follicular fluid with advancing patient age. Proceedings of the 52nd Annual Meeting of the American Society for Reproductive Medicine. Boston, Massachusetts. Abstract p-073, page S127.
  115. Marrs, RP, Ringler, GE, Vargyas, JM, Stein, AL, Schiewe, MC, Greene, J, Scrooc, M. High fertilization, cleavage and pregnancy rates using a simplified intracytoplasmic sperm injection (ICSI) procedure in human infertility treatment. Theriogenology 43: 303, 1996.
  116. Marrs, RP, Vargyas, JM, Stone, BA, Schiewe, MC, Scrooc, M. Use of ICSI for patients following a failed sperm penetration assay (SPA). Proc. 44th Ann. Pacific Coast Fertility Society. Mtg., Fertility Sterility (Suppl.), 1996.
  117. Marrs, RP, Schiewe, MC, Stein, AL, Greene, J, and Ringler, GE. Selective assisted hatching is beneficial but not mandatory for ICSI-derived embryos. Proc. 44th An. Pacific Coast Fertility Society Mtg. Fertility Steril, 1996. 
  118. Marrs, RP, Schiewe, MC, Massacesi, A., Barberi, C, and Santuari, E. Patient stimulation response and egg quality can adversely influence ICSI outcomes. Proc. Inter. Conf. ICSI: Serono Symp., Thessaloniki, Greece, Sept. 20-21, 1996.
  119. Barberi, C., Schiewe, MC, Santuari, P, and Marrs, RP. Successful treatment of cleavage failure in two ICSI patients. Proc. Inter. Conf. ICSI: Serono Symposia., Thessaloniki, Greece, Sept 20-21, 1996.
  120. Marrs, RP, Schiewe, MC, Scrooc, M, and Greene, J. ICSI outcomes
    are influenced by egg factor conditions. Proc. 52nd Ann. American Society Reproductive Medicine Mtg., Fertility Sterility (Suppl), pg. S39, 1996.
  121. Marrs, RP, Schiewe, MC, Massacesi, A., Ierardi, K., Amodei, M. Barberi, C. Giovenco, P., and Santuari, P. 1997. BRL cell coculture and assisted hatching of ICSI-derived human zygotes. Theriogenology 47: 252. 
  122. Stone, B.A., Vargyas, J.M., Ringler, G.E., Stein, A.L. and Marrs, R.P. (1996). Analysis of the determinants of 4,935 intrauterine insemination (IUI) cycles. Proceedings of the 52nd Annual meeting of the American Society for Reproductive Medicine, Boston, Massachusetts, November 2-7, 1996. Abstract P-156, page S165.
  123. Stone BA, Faridi R, Ong E, Marrs RP: Relationships between the Acrobeads score of human sperm, the capacity for penetration of zona-free hamster ova (SPA), strict sperm morphology and computer analysed (CASA) sperm movement characteristics. Proceedings of the 52nd Annual Meeting of the American Society for Reproductive Medicine. Boston, Massachusetts. November 2-7, 1996. Abstract P-229, page S199.
  124. Stein AL, Marrs RP, Stone BA: Numbers and quality of oocytes after induction of folliculogenesis in mice with Metrodin (MET), Pergonal (hMG), and Metrodin -HP (M-HP); Interaction with hCG. Proceedings of the 52nd Annual Meeting of the American Society for Reproductive Medicine. Boston, Massachusetts. November 2-7, 1996. Abstract P-193, page S182. 
  125. Qian C, Stone BA, Shiina Y, Marrs RP; HPLC profiles for steroidal hormones of human ovarian follicular fluid. Abstract P-193, page S182. 1996.
  126. Shiina Y, Stone BA, Hubbard GM, Schiewe MC, Marrs, RP; Levels of sex- hormone binding globulin (SHBG) in follicular fluid (FF) and in serum of patients undergoing controlled ovarian hyperstimulation. Proceedings of the 53rd Annual Meeting of the American Society for Reproductive Medicine. Cincinnati, Ohio. October 18-22, 1997.
  127. Stone BA, Vargyas JM, Ringler GE, Stein AL, Faridi R, Ong E, Marrs RP; Sperm motility as a determinate of the outcome of intrauterine insemination (IUI); Retrospective and prospective analyses. Proceedings of the 53rd Annual Meeting of the American Society for Reproductive Medicine. Cincinnati, Ohio. October 18-22, 1997.
  128. Marrs, RP, Schiewe, MC, Massacesi, K. Ierardi, Amodei, M., Barberi, C, and Santuari, E. Egg quality and ICSI outcomes are influenced by patient response to control ovarian hyperstimulation. Proc. Serono Symposium:Human Oocyte: From Physiology to IVF, Bologna, Italy, Pg. 99, April 1997.
  129. Marrs, RP and Schiewe, MC. Egg quality influneces ICSI outcomes. Proc. Serono Symposium: Human Oocyte: From Phsiology to IVF, Bologna, Italy, April 1997.
  130. Marrs, RP, Schiewe, MC, Massacesi, A, Santuari, E., Amodei, M., Barberi C. and Ierardi, K. Comparative development of ICSI-derived Human embryos in glucose-free phosphate-free simple media solutions. ESREA conference, Human Reproduction. (Suppl.) R-145, pg. 298, 1997.
  131. Marrs, RP, Schiewe, MC, Ringler, GE, Bennett, CJ, and Rothman, CM. Cryopreservation of Intact Testis Biopsies for ICSI. Proc. 53rd Ann. Amer. Soc. Reprod. Med. Mtg., Fertility and Sterility (Suppl), pg. S115, 1997.
  132. Marrs, RP, Schiewe, MC, Ringler, GE, and Stein, AL. Influence of Fertinex on oocyte phsiology and ICSI/IVF outcomes. Proc. 53rd Ann. Amer. Soc. Reprod. Med. Mtg., Fertility and Sterility (Suppl), pg. S222, 1997.
  133. Marrs, RP, Schiewe, MC, Massacesi, A, Santuari, E, Amodei, Barberi, C, and Giovenco, P. 1997. Comparative development of ICSI-derived human embryos in HTF, P-1, QB-XI and D3 media solutions. Proc. Serono Symposium: ART: State of the Art, Maui, HA, pg. 47, 1997.
  134. Qian C, Stone BA, Marrs RP: Selective isolation of serum estrogens by
    SPE cartridges prior to chromatographic analysis. Proceedings of Pittcon ’97. Atlanta, Georgia. Abstract 456. March 16-21, 1997.
  135. Qian C, Stone BA, Marrs RP: Direct analysis of underivatized steroids in Biologic fluid by gas chromatography-mass spectrometry. Proceedings of Pittcon ’97. March 16-21, 1997. Atlanta, Georgia. Abstract 1011.
  136. Schiewe MC, Ringler GE, Stein AL, Marrs RP, Influence of Fertinex
    on oocyte physiology and ICSI/IVF outcomes. Proc. 53rd Ann. Amer. Soc. Reprod. Med. Mtg., Fertil Steril (Suppl), pg. S222, 1997.
  137. Schiewe MC, Massacesi A, Santuari E, Amodei M, Barbieri C, Giovenco P, Marrs RP. Comparative development of ICSI-derived human embryos in HTF,P-1, QB-XI and D3 media solutions. Proc. Serono Symposium: ART:State of the Art, Maui, HA, pg. 47. 1997.
  138. Schiewe MC, Conia J, Tadir Y, Marrs RP. Laser assisted hatching using a 1480nm diode laser in a computer controlled non-contact mode: mouse model. Proc. 46th Ann. Pacif. Coast Fertil. Soc. Mtg. (P-16), Fertil. Steril. 69:595, 1998.
  139. Schiewe MC, Santuari E, Amodei, M, Barberi, Giovenco P, Massacesi A, Ierardi K, Marrs RP. Improved ICSI-ET success using a Cook Soft-Pass catheter. Proc. 46th Ann Pacif. Coast Fertil. Soc. Mtg. (P-17), Fertil. Steril. 69:595, 1998.
  140. Schiewe MC, Ringler GE, Stein Al, Scrooc M, Greene J, Marrs RP. Analysis of ICSI and IVF Outcomes in stimulation cycles using Fertinex alone or in combination with Pergonal or Metrodin. Proc. 46th Ann Pacif. Coast Fertil. Soc. Mtg (P-18), Fertil. Steril. 65:596, 1998.
  141. Qian C, Stone, BA, Marrs RP: Determination of underivatized B -estradiol in serum by routine stable isotope dilution / gas chromatography / mass Spectrometry. Proceedings of Pittcon ’98. March 1 –5, 1998. New Orleans, Louisiana Morial Convention Center, LA. Abstract 584.
  142. Qian, C, Stone, BA, Marrs, RP: A protocol for isolation of total steroids and for selective isolation of estrone and B-estradiol in serum by a mixed mode SPE. Proceedings of Pittcon ’98. March 1-5, 1998. New Orleans, Louisiana Morial Convention Center, LA. Abstract 631.
  143. Marrs, RP, Schiewe, MC, Ringler, GE, Bennett, CJ, Marchese, V, and Santuari E. Effectiveness of semen procurement method and spermatogenic cell type for ICSI of azoospermic and severe olioasthenospermic men. Proc. 46th Ann. Pacif. Coast Fertil. Soc. Mtg. (Fertility Sterility Suppl.), 1998.
  144. Zeitlin SI, Schiewe MC, Robinson ME, Ringler GE, Stein AL, Marrs RP, Rafer J, and Bennett CJ. The achievement of pregnancies using intracytoplasmic sperm injection in anejaculatory men. Proc. 54th Ann. Amer. Soc. Reprod. Med. Mtg., Fertil Steril (Suppl.1) 70:S268 (P-454) 1998.
  145. Massacesi A, Santuari P, Amodei M, Barbieri C, Giovenco P, Marrs RP, Schiewe MC. Comparative development of ICSI-derived human embryos in HTF, P-1, QB-XI and D3 media solutions. Proc. 54th Ann. Amer. Soc. Reprod. Med. Mtg., Fertil Steril (Suppl.1) 70: S94 (PO-253) 1998.
  146. Stone BA, Ong E, Marrs RP. Projecting Outcomes of the Zona-Free Hamster Sperm Penetration Assay (SPA) from Determinations of Acrosome Reactivity by Staining. Fertil Steril (Suppl. 1) 70: (P-735) 1998.
  147.  Stone BA, Faridi R, Ong E, Vargyas JM, Stein AL, Ringler GE, Marrs RP. Processing of Semen Samples Through Albumin Columns Fails to Increase the Likelihood of Male Offspring Following Intrauterine Insemination (IUI). Fertil Steril (Supp. 1) 70: (O-048) 1998.
  148. Stone BA, Faridi R, Ong E, Vargyas JM, Ringler GE, Stein AL, Marrs RP. Hormones in human seminal plamsa, their origins and their quantitative relationships with sperm numbers and sperm movement characteristics. Proceedings of the 54th Annual Meeting of the American Society for Reproductive Medicine and the 16th World Congress on Fertility and Sterility, Abstract P-033, S135, 1998.
  149. Stone BA, Faridi R, Ong E, Vargyas JM, Stein AL, Ringler GE, Marrs RP. Processing of semen samples through albumin columns fails to increase the likelihood of male offspring following intrauterine insemination (IUI). Proceedings of the 54th Annual Meeting of the American Society for Reproductive Medicine and the 16th World Congress on Fertility and Sterility, Abstract-048, p. S18.
  150. Stone BA, Ong E, Marrs RP. Projecting outcomes of the zona-free hamster sperm penetration assay (SPA) from determinations of acrosome reactivity by staining. Proceedings of the 54th Annual Meeting of the American Society for Reproductive Medicine and the 16th World Congress on Fertility and Sterility, Abstract P-735, p. 
    S358, 1998.
  151. Marrs RP, Stone BA. Determinants of the outcome of intrauterine insemination (IUI): Analysis of outcomes of 9, 963 consecutive cycles. Proceedings of the Pacific Coast Obstetrical and Gynecological Society.
  152. Stone BA, Vargyas JM, Ringler GE, Stein AL and Marrs, RP. The likelihood of pregnancy with consecutive failed cycles of intrauterine insemination (IUI). Proceedings of the 55th Annual Meeting of the American Society for Reproductive Medicine, 0-101, page S39, 1999.
  153. Stone BA, Hubbard GM, Vargyas JM, Ringler GE, Stein AL, and Marrs RP. Fasting serum insulin as a determinant of baseline serum levels of SHBG and free testosterone (FT), and of ovarian response to 
    gonadotropins (hMG), in non -PCOS classified in vitro fertilization (IVF patients. Proceedings of the 55th Annual Meeting of the American Society for Reproductive Medicine, P-003, S90, 1999.
  154. Stone BA, Ong E, Faridi R, and Marrs RP. Effects of low levels of ascorbic acid (AA) on survival of human sperm, and on outcomes of the zona-free hamster penetration assay (SPA). Proceedings of the 55th Annual Meeting of the American Society for Reproductive Medicine, P-242, p.S167, 1999.
  155. Stone BA, Vargyas JM, Ringler GE, Stein AL, and Marrs RP. Levels of antiphospholipid antibodies (APA) in serum during controlled ovarian hyperstimulation (COH); Relationship to serum estradiol (E2) level, day of stimulation, and pregnancy outcome. Proceedings of the 55th Annual Meeting of the American Society for Reproductive Medicine, P-143, p S135, 1999.
  156. Stone BA, Vargyas JM, Ringler GE, Greene J, and Marrs RP. Oocyte numbers, fertilization (IVF) rates of recovered oocytes, and pregnancy rates in 1035 cycles of controlled ovarian hyperstimulation (COH) with
    FSH alone (urinary FSH [uFSH], purified uFSH [hpFSH] or recombinant FSH [rFSH]; or with FSH and urinary gonadotropins (hMG). 56th Annual Meeting of American Society for Reproductive Medicine; October 2000, San Diego, CA.
  157. Marrs RP, and Stone BA. Use of Human Menopausal Gonadotropins (hMG) and Leuprolide Acetate in Poor Responder Patients. 57th Annual Meeting for American Society for Reproductive Medicine; October 2001, Orlando Florida.
  158. Marrs RP, Keye WR, Check JH, Schnell V, Surrey M, and Marshall DC. Evaluation of Mixed Protocols with Bravelle (hFSH) and Repronex (hMG) to Assess Their Clinical Efficacy (EMBRACE) in Subjects Undergoing In-Vitro Fertilization. Submitted. 2003.
  159. Marrs RP. Does the addition of LH have a benefit for patients of advanced reproductive age undergoing ART? A randomized comparative trial of recombinant human FSH (Gonal-F) alone or in combination with recombinant LH (Luveris) from day 6 of treatment. Reproductive BioMedicine Online, March, 2003. (accepted)

Publications

  • Marrs, RP, Friedman-Bloch, Lisa, Kirtland-Silverman, Kathy, Dr. Richard Marrs’ Fertility Book, Delacorte Press
Bravelle
Repronex